EM, B., C, H., R, W., K, Z., M, L., CK, D., . . . S, S. (2025). In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency. Pharmaceuticals (Basel, Switzerland), 18(11), . https://doi.org/10.3390/ph18111656
Chicago Style (17th ed.) CitationEM, Burger, et al. "In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency." Pharmaceuticals (Basel, Switzerland) 18, no. 11 (2025). https://doi.org/10.3390/ph18111656.
MLA (9th ed.) CitationEM, Burger, et al. "In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 11, 2025, https://doi.org/10.3390/ph18111656.